Perrigo Co PLC (PRGO)

PRGO (NYSE:Drugs) EQUITY
$87.27
neg -0.48
-0.55%
Today's Range: 86.34 - 89.07 | PRGO Avg Daily Volume: 2,996,000
Last Update: 06/28/16 - 4:01 PM EDT
Volume: 2,412,563
YTD Performance: -39.36%
Open: $89.04
Previous Close: $87.75
52 Week Range: $84.85 - $198.42
Oustanding Shares: 143,222,633
Market Cap: 13,034,691,829
6-Month Chart
TheStreet Ratings Grade for PRGO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 6 10
Moderate Buy 0 0 0 0
Hold 11 11 10 8
Moderate Sell 1 1 1 0
Strong Sell 0 0 0 0
Mean Rec. 2.56 2.56 2.35 1.89
Latest Dividend: 0.14
Latest Dividend Yield: 0.64%
Dividend Ex-Date: 05/25/16
Price Earnings Ratio: -121.35
Price Earnings Comparisons:
PRGO Sector Avg. S&P 500
-121.35 0.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-32.66% -53.95% -27.41%
GROWTH 12 Mo 3 Yr CAGR
Revenue -39.80 -1.00 0.00
Net Income -95.60 -1.00 0.00
EPS -95.80 -1.00 0.00
Earnings for PRGO:
EBITDA 0.00B
Revenue 2.77B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $2.00 $2.18 $8.32 $9.19
Number of Analysts 18 17 18 18
High Estimate $2.20 $2.56 $9.55 $10.90
Low Estimate $1.77 $2.02 $8.05 $8.33
Prior Year $2.18 $1.76 $7.59 $8.32
Growth Rate (Year over Year) -8.46% 23.66% 9.57% 10.54%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Timothy Collins

 | Jun 16, 2016 | 10:57 AM EDT

A lost leader in Celgene and a Perrigo rumor have put a scare in the charts.

By

James Passeri

 | Jun 13, 2016 | 12:14 PM EDT

Papa is set to meet with Walgreens management in hopes of ironing out "speed bumps."

By

The Deal

 | May 28, 2016 | 2:00 PM EDT

Problems with mesh products and high leverage might scare away a potential buyer. 

By

Doug Kass

 | May 13, 2016 | 8:51 AM EDT
AAPL made another near-term low, trading briefly under $90. It was down 2.35% on the day, but Apple announced a $1 billion investment in Chinese ride-sharing company Didi Chuxing. Is CEO Tim Cook serious? Monsanto (MON) became a possible takeover target of two different German companies. This led me to re-establish a medium-sized position in rival fertilizer company Potash Corp. (POT). I plan to buy more at current prices today. I did no trading yesterday other than buying some POT. :) I remain manifestly bearish and deep into the ursine territory. My net-short exposure is as high as it's been in two years. The S&P 500 futures were down 3.5 points at last check, indicating more selling pressure in today's regular session. The U.S. dollar strengthened. Oil fell 55 cents to $46.15 a barrel. Gold lost three beaners to $1,268 an ounce. Among agricultural commodities, wheat was -1, corn -1 and soybeans -4.50. Lumber was unchanged. Bonds were lower in price, with the iShares 20+ Year Treasury Bond ETF (TLT) losing $0.57. But 10- and 30-year U.S. Treasury yields both added two basis points. Municipal bonds were well bid, but closed-end muni funds were mixed. High-yield debt was slightly higher. The iShares iBoxx U.S. Dollar High Yield Corporate Bond ETF (HYG) finished +$0.09 and the SPDR Barclays High Yield Bond ETF (JNK) added $0.03. The Blackstone/GSO Strategic Credit closed-end fund (BGB) finished the day three pennies higher. Bank stocks were flat to lower, but brokerage stocks got hit -- led by a two-beaner drop in Goldman Sachs (GS). Insurers were slightly higher, with Geico/General Re parent Berkshire Hathaway (BRK.A, BRK.B) recovering from recent weakness. Old tech ended mixed. Energy was stronger again,
By

James Passeri

 | May 12, 2016 | 4:48 PM EDT

The drugmaker's quest to rebrand itself as a patient-first company is foundering over renewed controversy over drug pricing.

By

David Katz

 | May 12, 2016 | 8:00 AM EDT

Despite an earnings beat and upbeat outlook, its stock has suffered with other drug makers.

By

Doug Kass

 | May 11, 2016 | 4:33 PM EDT
The U.S. dollar weakened. Crude oil ramped up to $46.06, up $1.40, proving most pundits wrong both on the downside early this year and the upside recently.  As I have warned, few commodities forecasters are very rigorous in their projection process.  Me, I had a general and strong view that OPEC was dissolving and prices would drop last October. Today, I don't know.  Gold was up $12.40 to $1,277. Agricultural commodities: wheat -2.50, corn -3.25, soybean -5.25, oats -4.25. Lumber down 50 cents. Bonds rallied. The 10-year note yield dropped by two basis points to 1.74% and the long bond by three basis points to 2.58%. Municipals were well-bid, but closed-end municipal bond funds were mixed. Blackstone/GSO Strategic Credit Fund (BGB) was down six cents to just below $14. Banks fared well for most of the day but turned red in the mid-afternoon. Small losses, though. Financial Sector Select SPDR ETF (XLF), the object of my recent disaffection (I am short), was off 26 cents. Insurance generally declined, though Lincoln National (LNC) was flat. Berkshire Hathaway (BRK.B) continued to lose ground, down nearly $2 again today. Brokerages got hit; I covered too early this week. Private equity stocks continue to lag. Retail was the story of the day -- it was a nuclear holocaust. Nordstrom (JWN), my short, was down by $3.40. Macy's got whacked by $5.60. Others were a mess, too. Old tech was weak, led by IBM (IBM), down a beaner. Energy stocks failed to rally in the face of the commodity rise, but losses were contained. Schlumberger (SLB) and Exxon Mobil (XOM) were off fractionally. Auto stocks were lower. Ford (F) was off 20 cents and General Motors (GM) was down 27 cents. They seem to be rolling over after recent gains. Media was weighed down by the Disney miss. DIS was down $4.65 and Comcast (CMCSA) was off 60 cents. Consumer staples were hit across the board. Agricultural equipment performed well in a relative sense -- flat. Biotech was another group that gave a false signal yesterday. iShares Nasdaq Biotechnology ETF (IBB) was down 2%. Valeant (VRX) was down 5.5% and has no rally. My former speculative biotech basket was rotten to the core with large losses. Celgene (CELG) was down $2.50 and Gilead Sciences (GILD) down $2; I believe they are both value traps. (T)FANG was higher most of the day but got hurt with chatter over antitrust issues with Alphabet (GOOGL), down $7. AMZN is a monster, up another $12. Tesla (TSLA) was up small, though Netflix (NFLX) broke down $2.80. NOSH was unappetizing; Nike (NKE) was down $2, O'Reilly Automotive (ORLY) was off $6, Starbucks (SBUX) declined $1.20 (I am short and the shares appear to be rolling over; I might add to this position on any strength) and Home Depot (HD) slid $3. CRABBY's six components were lower.  In terms of individual stocks, Apple continues to stink up the joint (down nearly a beaner -- it remains in liquidation mode). Short or sell it, don't hold it! Twitter (TWTR) up flat, Potash (POT) continues weaker, Radian Group (RDN) is back down and Oaktree Capital Group (OAK) declined 85 cents and is getting back to my buying levels. Long fav DuPont (DD) slipped 30 cents. iShares MSCI United Kingdom (EWU), my short Trade of the Week, was down by only four cents. I remain short. Here are some great columns that appeared on Real Money Pro today: Jim "El Capitan" Cramer on how to win!  Gary "The Sun Will Come Out To" Morrow writes about Facebook (FB) -- he is not high on the stock but is a buyer on weakness.  The stock, like Amazon, continues to be a beast! Jared "Not Bob" Woodard features the latter company in his post.  Tim "Not Phil or Judy" Collins sees issues at Perrigo (PRGO).  Jeremy LaKosh on GM as a value play. He makes some solid points, but I remain short the name.   Tony Owusu sees a silver lining at Disney.
By

Timothy Collins

 | May 11, 2016 | 12:12 PM EDT

It reports tomorrow, but where will the company ultimately fall this quarter?

By

Doug Kass

 | May 10, 2016 | 1:52 PM EDT
"Papa's in the swing.He ain't too hip about that new breed babe.He ain't no drag.Papa's got a brand new bag."
By

Jim Cramer

 | May 10, 2016 | 6:40 AM EDT

And Joe Papa can't stop the world. 

Coming up towards midnight on the East Coast and futures trading suggests we might see sma...
First I want to share my daily chart that was already posted on twitter.  Note that the r...
Nike's (NKE) drop after reporting earnings, around 4:15 PM, should not have surprised RMP ...
Only a climb in the Emini S&P 500 that pushes up through 2065 on a sustained basis wil...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.